Genome-Wide Short Hairpin RNA Screen for Senescence Genes by Doughty, Tyler W.
Worcester Polytechnic Institute
Digital WPI
Major Qualifying Projects (All Years) Major Qualifying Projects
April 2009
Genome-Wide Short Hairpin RNA Screen for
Senescence Genes
Tyler W. Doughty
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/mqp-all
This Unrestricted is brought to you for free and open access by the Major Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Major Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Doughty, T. W. (2009). Genome-Wide Short Hairpin RNA Screen for Senescence Genes. Retrieved from
https://digitalcommons.wpi.edu/mqp-all/1793
MQP-BIO-DSA-0612 
 
 
IDENTIFICATION OF GENES REGULATING SMURF2-INDUCED 
SENESCENCE IN HUMAN FIBROBLASTS USING  
GENOME-WIDE GENE KNOCKDOWN SCREENING 
 
 
A Major Qualifying Project Report 
Submitted to the Faculty of the 
WORCESTER POLYTECHNIC INSTITUTE 
in partial fulfillment of the requirements for the 
Degree of Bachelor of Science  
in 
Biology and Biotechnology 
 
by 
 
_________________________ 
Tyler Doughty 
 
 
April 30, 2009 
 
 
APPROVED: 
 
_________________________   _________________________ 
Hong Zhang, Ph.D.     David Adams, Ph.D. 
Cell Biology      Biology and Biotechnology 
Umass Medical Center    WPI Project Advisor 
Major Advisor 
 2
ABSTRACT 
 
 
Smurf2 is an E3 ligase previously identified by our laboratory to be up-regulated 
by telomere shortening in senescent cells, and is sufficient to induce senescence in early 
passage human cells.  Both the p53 and pRB senescence pathways are utilized by Smurf2 
to induce senescence, but the precise mechanism of Smurf2-induced senescence remains 
unknown.  The purpose of this project was to identify genes downstream of Smurf2 in the 
senescence pathways using a genome-wide short hairpin RNA (shRNA) screen in human 
fibroblasts. Using this strategy, I have identified 13 potential modulators of Smurf2-
induced senescence, including AHCYL1 and CDC42BPA.  Preliminary analysis 
indicates that AHCYL1 regulates senescence via the Smurf2-p53 pathway.  
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BACKGROUND 
 
 
 
Replicative Senescence  
The in vitro culture of normal human fibroblasts results in a finite number of cell 
divisions before cells reach replicative senescence, a permanent arrest of growth 
(Hayflick and Moorehead, 1961). This arrest occurs in the G1/G0 stage of cell division 
(Sherwood et al., 1988), and is characterized by a variety of changes, including 
alterations in gene expression (Campisi et al., 1996), positive staining for B-gal at pH 6 
(Dimitri et al., 1995), and cells become larger, flattened, and granular (Goldstein, 1990).  
 
Telomerase, and Telomere Shortening 
Replicative senescence has been shown to be activated by the shortening of 
telomeres (Harley, 1991), specialized structures found at the end of chromosomes that 
contain variable numbers of DNA repeats of TTAGGG in humans (Blackburn, 2001). 
Telomeres are shortened each cell division due to the inability of DNA polymerase to 
replicate the ends of linear chromosomes completely (Watson, 1972). This shortening is 
counteracted by the non-template activity of the enzyme telomerase  which adds 
telomeric repeat sequences to the end of the chromosome (Shippen-Lentz and Blackburn, 
1989). The incomplete fill-in by DNA polymerase leaves a 3’ overhang with the 
telomeric repeat sequence (Blackburn, 2001). 
Most somatic cells have no telomerase activity (Kim et al., 1994), this means that 
they do not replace the lost telomeric repeats after DNA replication, resulting in the 
shortening of telomeres during each replication cycle (Zhang, 2007). Supporting the 
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hypothesis that telomere shortening activates senescence, it has been shown that 
expression telomerase’s catalytic subunit (TERT) in cells susceptible to replicative 
senescence can prevent telomere shortening and delay senescent arrest by >20 doublings 
(Bodnar et al., 1998), whereas inhibition of telomerase in immortal cells limits their 
reproductive lifespan (Zhang et al. 1999), and furthermore, the longer telomeres are when 
telomerase is inactivated in immortal cells the greater the number of cell doublings before 
the onset of replicative senescence (Blackburn, 2001).  
The precise mechanism by which telomere shortening activates replicative 
senescence has yet to be elucidated. One hypothesized mechanism suggests that the 
senescence pathway is triggered by the decrease in the amount of telomeric repeats 
leading to a change in the structure of the telomeric cap, a protein/DNA structure thought 
to keep DNA safe from degradation, leading to uncapping (Blackburn, 2001). This 
uncapping occurs naturally when telomeres shorten to critical lengths, and in the presence 
of telomerase, this uncapping allows telomeric repeats to be added (Blackburn, 2001). 
However, if telomerase is absent, telomeric caps remain open, potentially contributing to 
the aging phenotype via a yet unidentified mechanism (Blackburn, 2001). 
 
Multiple Pathways Lead to Senescence 
 
An early set of experiments showed that certain immortal human cell lines can be 
induced into replicative senescence by cellular fusion with certain other immortal human 
cell lines (Pereira-Smith and Smith, 1988). The experiment showed that multiple groups 
of complementary immortal cell lines exist, and when members of different groups are 
fused, they no longer show immortal cell division. This result suggests that immortality 
in oncogenic cell lines is caused by the mutation of different senescence pathways, which 
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can be corrected by the introduction of an intact version of that pathway (even from 
another immortal line). In short, this data suggests that senescence is dominant, and that 
multiple pathways can cause senescence (Pereira-Smith and Smith, 1988). 
 
p53 Senescence Pathway 
 
ATM (ataxia-telan-giectasia mutated) and ATR (Rad3-related) kinases are 
members of the PI3K DNA damage response pathway, and have been shown to be up-
regulated during senescence (Herbig et al., 2004). ATM is activated in response to 
dsDNA breaks, while ATR is activated by the presence of G-rich ssDNA, both of which 
may be present as the telomeres shorten (Herbig et al., 2004). These kinases are both 
capable of phosphorylating p53, which has been shown to trigger replicative senescence 
(Herbig et al., 2004, see Figure-1).  
p53 triggers replicative senescence by binding DNA specifically and activating 
the transcription of growth inhibitory factors. Over-expression of p53 inhibits cell 
proliferation (Chen et al., 1990), while inhibition of p53 extends the proliferative lifespan 
in fibroblasts (Atadja et al., 1995). This inhibition of replicative potential is due to the 
activation of p53 which occurs in late passage cells during replicative senescence in 
response to telomere shortening (Goberdhan, 2005). This activation is the result of 
phosphorylation of p53 by ATM and/or ATR, which has been shown to raise p53’s DNA 
binding activity; therefore up-regulating the transcription of growth regulating factors 
(Atadja et al., 1995). One of the major factors transcriptionally activated by p53 is p21, 
which has been linked with inhibition of normal cell growth in fibroblasts (Atadja et al., 
1995).  Human fibroblasts with p21 null mutations are able to escape senescence (Brown 
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et al. 1997), while expression of p21 has been shown to be sufficient in some cells to 
induce senescence (Goberdhan, 2005). 
 
 pRB Senescence Pathway 
Loss of Retinoblastoma, or pRB, expression has been shown to allow human 
fibroblasts to escape senescence (Wei et al., 2003). This senescent escape is thought to be 
the result of a pathway that acts alongside the p53 senescence pathway to keep senescent 
cells in growth arrest (Goberdhan, 2005).  Retinoblastoma is found in a hypo-
phosphorylated state in senescent cells (Goberdhan, 2005), this state increases pRB’s 
ability to act as a transcriptional repressor; by allowing it to bind to and inactivate 
transcription factors (Ezhevsky et al., 1997). One notable transcription factor that pRB 
binds to and represses when hypophosphorylated is E2F, an important factor in DNA 
synthesis (Ezhevsky et al., 1997). 
The hypophosphorylation of pRB is thought to be initiated/maintained by p16 and 
p21 (Stein et al. 1999; Goberdhan, 2005), both of which inhibit cyclin dependent kinases 
(CDKs), and are up regulated during senescence in human fibroblasts (Itahana et al., 
2003).  p21 may lead to the hypophosphorylated phenotype by interfering with the 
CDK2/Cyclin E kinases (Goberdhan, 2005). This link between p21 and pRB suggests 
that p53 can play a role in pRB senescence, by turning on p21, which inhibits pRB’s 
kinases (see Figure-1). However, pRB can also be activated by p16 independently of the 
p53 pathway.  p16 and its upstream activators have been shown to induce senescence in a 
pRB dependent, but p53 independent manner (Itahana et al., 2003). This suggests that 
pRB can be activated by p53 and can cause senescence on its own. 
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Figure 1: An Overview of the p53 and pRB Senescence Pathways.  Shown are simplified signaling 
pathways that lead from senescence signals (stress, telomere shortening, DNA damage) to the senescence 
phenotype.  Note that p53 and E2F (repressed by pRB) are transcription factors, and that upregulation of 
p53 and/or inhibition of E2F can cause changes in the expression of many genes, leading to the senescence 
phenotype. 
 
 
 
Smurf2 and Senescence 
 
Figure-1 above does not show the entire picture, due to the lack of complete 
understanding of all the factors involved and their connections to one another. The least 
established portions of this pathway are the key genes regulated by p53 expression and 
E2F inhibition, and the genes that act upstream of ATM/ATR and p16. One of the genes 
upstream of p16 and ATM/ATR is Smurf2, a protein of interest in our laboratory. 
 
Smurf2 Protein Description 
 
Smurf2, or SMAD Specific E3 Ubiquitin Protein Ligase 2, is a human gene 
encoding a 748 amino acid protein involved in the ubiquitination of SMAD2, which leads 
 to proteosomal degradation of SMAD2, a key regulator of TGF
2000).  
          
 
 
 
 
Figure 2: Diagram of the Smurf2 Protein
(yellow) which bind proline rich regions of other proteins
HECT domains (Chen and Sudol, 1995).
required for Smurf2’s ubiquitin ligase function.
 
 
Smurf2 and Senescence 
Microarray analysis in our laboratory
response to telomere reduction, indicating that 
senescence (Zhang and Cohen, 2004). Further study showed that early passage 
fibroblasts, including WS1 cells used in this 
at the levels similar to senescent cells showed premature replicative 
and Cohen, 2004).  Moreover, the same 
expression were induced to senesce in the presence of Smurf2 (Zhang and Cohen, 2004).
Even Smurf2 mutants that are unable to perform ubiquitin ligase activity 
(specifically a substitution C716A that disrupts the catalytic pocket) are able to induce 
replicative senescence in fibroblasts, regardless of hTERT presence (Zhang and Cohen, 
2004).  This up-regulation of Smurf2, or Smurf2 C716A, sufficient for induction o
senescence, did not correlate with significant changes in Smad2 or TGF
cell lines, suggesting that the Smurf2’s ligase activity is not required for senescence 
(Zhang and Cohen, 2004). 
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-β signaling (Lin et al., 
           
.  The Smurf2 protein has three WW domains 
.  Smurf2 also contains C2 and 
 A cysteine (C) at position 716 of the protein is 
 
 indicated that Smurf2 levels increase in 
this protein may be involved in replicative 
MQP, that were induced to express Smurf2 
senescence (Zhang 
cell lines first made immortal by hTERT 
f 
-β levels in the 
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Smurf2 and p53/pRB 
 
Smurf2 has been shown to induce senescence in the absence of an intact p53 
pathway or pRB pathway (Zhang and Cohen, 2004). However, if both pathways are 
knocked out, Smurf2 expression does not lead to senescence, thus indicating that Smurf2 
affects both the p53 and the pRB senescence pathways (Zhang and Cohen, 2004).  
Two processes have been identified by which Smurf2 can influence pRB 
senescence (Figure-3). First Smurf2 acts to up-regulate p16 by degrading ID1/ID3 via its 
ubiquitin ligase function (Kong et al., unpublished). This degradation of ID1/ID3 
increases p16 levels because ID1/ID3 functions to repress p16 transcription (Hara, 1996).  
Second Smurf2 increases p21 levels which blocks E2F via pRB (Cui et al., unpublished). 
Data suggests that Smurf2 increases p21 by signaling through a Notch3 intermediate (Cui 
et al., unpublished). The process by which Smurf2 influences p53 senescence has yet to 
be elucidated. The focus of this MQP project is to identify other effectors turned on by 
Smurf2 which play a role in this pathway. 
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Figure 3: Smurf2’s Relation to p53 and pRB Senescence.  Smurf2 is up regulated in response to 
senescence signals, and its up-regulation has been shown be sufficient to cause senescence in early passage 
fibroblasts. Smurf2 has been shown to up-regulate p16 mRNA and p21 levels, via suppression of ID1/ID3 
and up-regulation of Notch3, respectively. Smurf2 has been shown to cause senescence in a pRB 
independent manner, and cannot cause senescence independently of pRB and p53; suggesting a link (dotted 
arrow) between Smurf2, p53, and senescence. 
 
 
Identification of Genes Downstream of Smurf2 Using shRNA Screening 
 
This MQP study focused on the identification of signaling factors downstream of 
Smurf2, which play a key role in the cellular senescence pathway. I  hypothesize that 
deficiency of an important signaling gene downstream of Smurf2 in the senescence 
pathway would interfere with the Smurf2-induced signal and consequently would allow 
primary fibroblasts to escape Smurf2-induced senescence. To test this hypothesis and 
identify genes downstream of Smurf2 in the senescence pathway, I used short hairpin 
RNA (shRNA) to systematically knockdown genes and identify candidate genes whose 
knockdown affects Smurf2-induced senescence.    
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The shRNA library was tested using commercially-obtained pools containing 
shRNA constructs inserted into plasmids capable of being packaged into lenti-virus. 
Pools used were from the Expression Arrest GIPZ Lentiviral shRNAmir Library from 
Open Biosystems. These shRNA constructs contained a hairpin sequence; comprised of 
two 22bp long sequences that would basepair to one another when translated to mRNA 
(see Figure-4).  
*Figure from Open Biosystems, Expression Arrest GIPZ lentiviral shRNAmir library product information. 
 
Figure 4: Design of the shRNAmir Hairpins.  The shRNAmir system incorporates two 22 base 
pair sequences capable of binding each other on a transcribed mRNA. The dsRNA causes a 
cellular drosha/dicer response leading to RNA interference of transcript with an identical 22bp 
sequence.  
 
 
When expressed, these shRNA constructs form a hairpin, which are cut by 
dicer/drosha resulting in two small interfering RNA, or siRNA, one that targets a known 
gene and one that is its antisense and has no function (see Figure-5). The sense siRNA 
binds to the complementary mRNA transcript sequence and destroys that transcript via 
the same dicer/drosha mechanism, resulting in expression arrest of that transcript (see 
Figure-5). The total number of unique shRNA constructs in the pools tested in this 
project was 30,000. This large number of unique shRNA constructs was utilized to 
identify potential genes that allow an escape of senescence.  Cells were infected at an 
 14
MOI of 0.1 (a titer of virus predicted to infect individual cells with a single shRNA 
construct), and selected using puromycin (shRNA expressing virus encodes resistance to 
puromycin). The cells that received viral constructs survive, and are presumed to be 
producing a single 22bp siRNA capable of interfering with a single mRNA.  This 
infection was then followed by infection with Smurf2-expressing viruses shown to cause 
cellular senescence in fibroblasts and another round of selection. This second selection 
incorporated puromycin to ensure the cells are expressing the shRNA encoding virus, and 
hygromycin (encoded by Smurf2 expressing virus) to ensure the cells are expressing the 
Smurf2 encoding virus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Figure from Open Biosystems, Expression Arrest GIPZ lentiviral shRNAmir library product 
information. 
 
Figure 5: shRNAmir Expression Arrest Mechanism. Cells that are transduced with a single 
virus containing a single shRNAmir construct can lead to expression arrest of a single transcript.    
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PROJECT PURPOSE 
 
Previous experiments in our laboratory indicated that over-expression of Smrf2 
protein in early passage fibroblasts induces senescence (Zhang and Cohen, 2004).  
Smurf2 has been shown to induce senescence in the absence of an intact p53 pathway or 
pRB pathway, but if both pathways are knocked out Smurf2 expression does not lead to 
senescence.  Thus, Smurf2 may affect both the p53 and the pRB senescence pathways 
(Zhang and Cohen, 2004).  However, the complete set of genes involved in senescence 
and their interactions with one another have yet to be elucidated.  
The purpose of this project was to identify potential genes in the senescence 
pathway that lie downstream of Smurf2 in order to facilitate a better understanding of 
senescence. Pools of shRNA encoding plasmids (30,000 unique shRNAs were tested in 
this project) were packaged into lentiviruses, and used to infect primary fibroblasts at a 
multiplicity of infection (MOI) of 0.1; to infect an average of one in 10 cells to ensure a 
single viral integration per infected cell. Cells were then infected with Smurf2 expressing 
virus to induce senescence. I hypothesized that cells that continued to grow after 
challenge with Smurf2 might contain an shRNA construct that interfered with the 
expression of a gene involved downstream of Smurf2 in the senescence pathway; and that 
knockdown of this gene disrupted the senescence signal elicited by Smurf2, thus allowing 
continued growth. Cells that escaped senescence grew into colonies, from which genomic 
DNA was extracted. PCR was run to amplify the shRNAmir construct contained by the 
cells of the colony. Sequencing later identified the siRNA sequence encoded by the 
senescence escaping cells, which was used to identify the gene knocked down in the 
escaping cells. 
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METHODS 
 
 
DNA Cloning 
 
 DNA cloning was utilized in this project to amplify plasmid constructs used for 
viral packaging. These plasmids included pMD2-VSVG, pCMVdR8.74, and dsRed. 
 
Cell Transformation 
Cell transformation was performed in XL-2 E. coli cell suspensions. Plasmid 
DNA was typically added at a concentration of 5 µg per sample. Samples were kept on 
ice for 30 minutes, heat shocked at 42˚C for 30 seconds, then cooled on ice for 2 minutes. 
Cells were then cultured under ampicillin selection. When confluent, cultures were spun 
down at 4000 RPM, and plated on ampicillin plates. The next day single colonies were 
picked and amplified.  Plasmids from these samples were collected via miniprep. 
            
 Plasmid Isolation  
Plasmid DNAs in this project were isolated using Quiagen’s QIAPrep® Spin 
Miniprep Kit. 
  
DNA Transfection and Colony Forming Unit Determination 
This project required the stable expression of plasmid constructs in primary cells. 
In order to achieve this, DNA was delivered by lenti-viral constructs which integrate their 
contents into the genome of the infected host cell resulting in stable expression. Viruses 
packaged in this project included thirteen pGIPZ pools of shRNA plasmid constructs, 
Smurf2, and Smurf2 C716A (ligase mutant) plasmid constructs, and AHCYL1 and 
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CDC42BPA shRNA constructs.  Colony forming units of each virus were quantitated to 
infect the primary cells in the screen at the proper multiplicity of infection. 
 
DNA Transfection in 293T  
  Human embryonic kidney 293T (HEK-293T) cells were plated in DMEM 
medium with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL 
streptomycin. These cells were cultured in a 37˚C incubator at 5% CO2 on 15cm tissue 
culture dishes. When their density was approximately 80% confluent, cells were freshly 
plated at a density of 3.6 x 106 cells/ml on 10cm tissue culture dishes.  Once the plates 
achieved ~70% density, they were transfected. 
 Transfection was performed in the 10cm plates using CaCl2/HBS transfection. 
The DNA to be packaged was mixed in a 15mL falcon tube with 6.5 µg of lenti-viral 
packaging vector pMD2-VSVG, 3.5 µg of lenti-viral envelope vector pCMVdR8.74, and 
0.2 µg of dsRed (marker). The total volume of this mixture was raised to 437.5 µl using 
0.1% TE.  CaCl2 was then added drop wise to the tube while vortexing at speed 7. Next, 
500 µl of 2X HBS was added to the mixture drop wise. The final solution was added drop 
wise onto the HEK-293T cells in 10 ml of media. Twenty hours later the cells were 
observed under fluorescence microscopy for the presence of dsRed; plates with >50% of 
cells expressing dsRed were aspirated and fed with fresh media. Supernatants containing 
lentivirus were collected 24 hours later, and stored at -80˚C to eliminate any living 
cellular contaminants.  
 
Colony Forming Unit Determination 
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 Colony forming units (CFUs) were determined for each virus made in this project. 
CFUs were determined in HT1080 cells plated at 5 x 104 cells per 60cm plate. Each virus 
was used to infect four plates; three plates received a serial diluted volume of viral 
supernatant (10 µl, 1 µl, or 0.1 µl), and one plate was used for a mock infection. All 
infections were performed in DMEM medium with 10% FBS, 100 U/mL penicillin, 100 
µg/mL streptomycin, and 4 µg/mL polybrene. Twenty-four hours post infection, cells 
were aspirated and cultured in base media for 24 hours.  After 24 hours, cells were plated 
in base media containing 1 µg/mL puromycin or 300 µg/mL hygromycin (depending on 
the resistance encoded on the plasmid). 
 Seven to ten days post infection, all plates were stained with 1% Crystal Violet in 
3% ethanol for 5 minutes. Colonies on each plate were counted in order to determine the 
colony forming units per micro liter of viral supernatant. 
 
shRNA Screening  
 Gene knockdown screening using shRNA constructs allowed for the identification 
of genes involved in Smurf2-induced senescence. Two shRNA screens were run in this 
project; MOI 0.1 shRNA library with a Smurf2 challenge and MOI 0.1 shRNA library 
with a C716A challenge. 
 
Cell Infection with shRNA Encoding Virus 
WS1 human embryo fibroblasts were plated at 5 x 105 cells per 100cm plate. Each 
100cm plate was infected with a single shRNA pool’s viral supernatant at MOI 0.1 in 
media containing 4 µg/mL polybrene. Two 60cm plates were plated at 5 x 104 and were 
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mock infected (exposed to media containing 4 µg/mL polybrene without receiving viral 
supernatant).  
 
Puromycin Selection 
            The shRNA plasmid packaged into virus in this project encoded puromycin 
resistance. Two days post infection cells were challenged with media containing 1 µg/mL 
puromycin. The mock infected plate was clear after about 72 hours of puromycin 
exposure.  At this time the infection below was performed.  
 
Cell Infection with Smurf2/C716A Encoding Virus 
 WS1 cells that survived puromycin exposure were then infected with Smurf2 viral 
supernatant that corresponded to 2 x 105 Smurf2 virions per 100cm plate. This infection 
was performed in media containing 4 µg/mL polybrene, alongside a mock infected 60cm 
plate. 
 
Puromycin/Hygromycin Selection 
 The Smurf2, and Smurf2 C716A viruses used in this project encoded hygromycin 
resistance. Two days post infection with Smurf2/C716A, cells were challenged with 
media containing 0.5 µg/mL puromycin and 150 µg/mL hygromycin. Cells were 
maintained in this media for twenty days until colonies formed in the 100cm plates. 
 
Isolation of Genomic DNA 
 Genomic DNA was isolated from the WS1 colonies that resulted from the shRNA 
screen. These colonies were isolated by spot trypsinization, and cultured in 24-well plates 
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separate from each other.  When cells reached ~80% confluence on the 24-well plate, 
they were trypsinized, and genomic DNA was isolated using Quiagen’s Gentra® 
Puregene® Core Kit A. 
   
Polymerase Chain Reaction 
 Genomic DNA extracted from each screen was amplified via Polymerase Chain 
Reaction (PCR) using primers that allowed amplification of a 602 bp region of the pGIPZ 
plasmid construct shown below in Figure-6. Amplification was facilitated by Taq DNA 
Polymerase purchased from New England Biolabs. The 602 bp region amplified included 
the siRNA construct sequence (shown as blue in the diagram) and the conserved loop 
sequence (shown as green in the diagram) that was expressed in the cells of a given 
colony. The amplified DNA from each colony was sent for sequence verification. 
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*Figure Adapted from Open Biosystems, Expression Arrest GIPZ lentiviral shRNAmir library product 
information. 
 
Figure 6: PCR Amplification of shRNA-miR Insert.  Primers were designed to amplify a 602 bp region 
of the shRNA-mir insert. This 602 bp region included the 22 bp 5’ siRNA and 3’ siRNA which form a loop 
in the mRNA by base pairing, leading to RNA interference.   
 
    
Sequencing 
 DNA amplified via PCR was purified and sent to Genewiz Inc. for sequencing.   
 
Clone Confirmation 
 Two of the clones, AHCYL1 and CDC42BPA, identified in the shRNA gene 
knockdown screen were ordered individually from Open Biosystems for further study. 
These specific shRNA constructs came in plasmid form, and were transformed, isolated, 
and packaged into lentivirus as described above. WS1 cells were infected with either non-
silencing control shRNA, shRNA that knocked down AHCYL1, or shRNA that knocked 
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down  CDC42BPA. This initial infection was carried out at MOI  0.5 in separate 100cm 
dishes, alongside mock infected controls.  
When mock control plates were clear, each of the three samples were plated on 6-
well plates (4 wells each) at 3.5 x 106 for β-gal and crystal violet staining, and on four 
100cm plates at 5 x 105; three of these plates were used for subsequent infection with 
Smurf2, Smurf2 C716A, or GFP, the fourth plate was used for RNA extraction. 
After mock infected plates were clear, each sample was plated at 3.5 x 106 cells 
per well on 6-well plates (4 wells for each sample) for β-gal and crystal violet staining, 
and at 2 x 104 cells per well on 6-well plates (6 wells per sample). 
  
RNA Isolation 
 RNA was isolated from cells pre-Smurf2 exposure to analyze the level of gene 
knockdown in the presence of each shRNA construct. RNA was isolated using a Quiagen 
RNeasy® Mini Kit.  
 
RT-PCR 
Invitrogen Superscript® II Reverse Transcriptase was used to facilitate cDNA 
synthesis via RT-PCR.  
 
Crystal Violet Staining 
 Crystal Violet staining was performed in 6-well plates that were plated at 3.5 x 
104 cells per well 72 hours after plating. Cells were washed with PBS, then stained with 
1% Crystal Violet in 3% ethanol for 5 minutes. Cells were washed again, then 
photographed at 10X magnification. 
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Growth Curves 
Growth curves were created from 6-well plates that were plated at 5 x 104 cells 
per well for each sample. One well of each sample was counted each day for six days 
(starting the day after the cells were plated) in a Beckman Coulter® Z1 Particle Counter 
three times. The average of the three counts was recorded for each sample.   
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RESULTS 
 
 
The purpose of this project was to identify potential genes in the senescence 
pathway that lie downstream of Smurf2 in order to facilitate a better understanding of 
senescence.  
 
Production and Testing of shRNA Viral Library  
 
Transfections were performed in HEK-293T cells to package all virus types 
(shRNA-expressing and Smurf2-expressing) used in this project. DsRed was included in 
all transfections alongside packaging constructs as a marker for transfection efficiency. 
Figure-7 below shows a representative DsRed fluorescence in HEK-293T pre-
transfection and post-transfection. The strong dsRed fluorescence in the right panel 
indicates an efficient transfection of the plasmid construct into the HEK-293T cells. 
 
 
Figure 7: HEK-293T Transfection Efficiency. HEK-293T transfection efficiency is shown by dsRed 
fluorescence pre-transfection (left) and post-transfection (right) for a typical transfection carried out in this 
project. 
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The Colony Forming Units, or CFU, for each of the viruses packaged in this 
project were determined in HT1080 cells. This was accomplished by plating HT1080 
cells in p60 plates at 5x104 cells per plate, then infecting with virus. Viral infection was 
performed for all the pools of the library, all Smurf2 transfections,  CDC42BPA 
transfections, and AHCYL1 transfections. All viral supernatants were plated at 10ul, 1ul, 
and 0.1ul per plate, and were run alongside a control with polybrene only. Figure-8 below 
shows example crystal violet stained plates from shRNA pool #1 fifteen days post 
infection.  In this case, plate B shows a countable number of colonies, and was used to 
determine the viral titer. 
 
 
 
Figure 8: shRNA pool #1 HT1080 CFU Plates. A. Mock Infection. B. 0.1ul shRNA pool #1 supernatant 
added, 97 colonies on plate indicating a CFU of 970virus/mL. C. 1.0ul shRNA pool#1 viral supernatant 
added, too many colonies to count. D. 10.0ul shRNA pool#1 supernatant. 
 
 
shRNA Screen for Genes Involved in Smurf2-Induced Senescence 
Genomic DNA extracted from the screens run in this project contained a single 
integrated shRNA construct, which was amplified using the two primers shown in 
Figure-6. These primers amplified a 602bp region of the shRNA construct that included 
the 22bp siRNA regions. The amplified DNA was run on a gel to assess the purity of 
each sample before sending samples for sequencing. Figure-9 below shows a gel 
separation of some of the constructs amplified in this MQP.  
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Figure 9: PCR Purity Gel. 3ul of each PCR amplified sample was run on a gel alongside a 100bp ladder  
to assess the purity of each sample. Samples in lanes 2-5, 7-8, 10, and 13-14 from this gel were deemed 
pure enough to sequence. 
 
 
Table I below shows the genes identified in the screens run in this MQP. The first 
screen challenged the cells with Smurf2 wild-type expression, the second with Smurf2 
C716A expression. Thirteen genes were identified in total from 24 colonies that escaped 
senescence in the two screens. Genes were identified from the sense siRNA sequence 
using BLAST and BLAT software.  Table I shows the genes that were targeted, the 
amount of base pairs that match between the gene and the siRNA, the sense siRNA 
sequence, and the chromosome locus of the gene identified.  S-adenosylhomocysteine 
hydrolase-like 1 and CDC42-binding protein kinase alpha isoform A are highlighted in 
this table because they were studied further in this MQP in an attempt to confirm that 
they operate downstream of Smurf2 in senescence.  
  
500bp 
600bp 
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Pool 
# 
Smurf2 
Type Gene name 
Identity 
Match 
Chromosome 
Locus Sense siRNA sequence 5' -> 3' 
1 Normal Inter-genic sequence 22/22 20q13.12 CCCAGCCTTAGTATTGATTCTA 
2 Ligase Mutant 
Hypothetical protein 
LOC9729 (C6orf174) 21/22 6q22.33 ACAACAGAGTCTGCATTGCAAA 
2 Normal V2LHS_214049 21/22 12q12 CGCTAATGATGCTGCAACATAA 
2 Normal N/A No 
match None AGCTCCTCTGTTAATGAGATTA 
3 Ligase Mutant 
S-adenosylhomocysteine 
hydrolase-like 1 21/22 1p13.3 ACCCATTTCTTAGCTGCTGAAA 
3 Normal Zinc finger, RAN-binding domain containing 1 21/22 10q26.13 CGGAACTTGAAGTAGACTTTAA 
3 Normal Ubiquitin domain-
containing protein 2 21/22 5q35.1 CAGGACTATGTTGTACAGGTTA 
4 Ligase Mutant 
Abhydrolase domain 
containing 7 21/22 1p22.1 ACCATTCATCGACAGAATTATA 
5 Ligase Mutant Arylsulfatase D isoform 21/22 Xp22.3 CGCATGGCTTATATGGTGATAA 
6 Ligase Mutant 
CDC42-binding protein 
kinase alpha isoform A 21/22 1q42.11 CGCATCTAATATCATAACAGAA 
6 Ligase Mutant Zinc finger protein, X-linked 22/22 Xp22.11 CGCAAATGGATGACAATGAAAT 
6 Normal Kelch-like 10 21/22 17q21.2 CGCTGAGTACTTCATGAACAAT 
6 Normal N/A No Match None CCGGCTGAATTATCGGTGATAA 
 
Table I:  Thirteen Candidate Genes That May Act Downstream of Smurf2.  Table I is a compilation of 
all sequencing data collected in this project. The genes that each siRNA targeted are shown, along with the 
amount of nucleotides that match between the siRNA and the gene. Further research supported the 
hypothesis that S-adenosylhomocysteine hydrolase-like 1 (AHCYL1) and CDC42-binding protein kinase 
alpha isoform A (CDC42BPA) might act downstream of Smurf2 in senescence. Some Clones were isolated 
from a ligase mutant Smurf2 challenge screen and some were isolated from a wild-type Smurf2 challenge 
screen. 
 
  
Verification of AHCYL1 and CDC42BPA 
S-adenosylhomocysteine hydrolase-like 1 (AHCYL1) was one of the genes from 
Table-1 that I attempted to confirm as acting downstream of Smurf2 in senescence in this 
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MQP. Figure-10 below shows AHCYL1’s protein sequence aligned with its homolog 
protein AHCYL2’s sequence. Deficiency of AHCYL2 has been shown to allow 
fibroblasts to escape p53-induced senescence (Berns et al., 2004).  The two proteins are 
strongly conserved, so AHCYL1 may also play a role in sensesence escape. 
  
 29
 
                    1                                               50 
Human AHCYL1    (1) -------------------------------------------------- 
Human AHCYL2    (1) MSVQVVSAAAAAKVPEVELKDLSPSEAESQLGLSTAAVGAMAPPAGGGDP 
   Consensus    (1)                                                    
                    51                                             100 
Human AHCYL1    (1) ---MSMPDAMPLPGVG-------------------------EELKQAKEI 
Human AHCYL2   (51) EAPAPAAERPPVPGPGSGPAAALSPAAGKVPQASAMKRSDPHHQHQRHRD 
   Consensus   (51)        D  PLPG G                             Q     
                    101                                            150 
Human AHCYL1   (23) EDAEKYSFMATVTKAP---KKQIQFADDMQEFTKFPTKTGRRSLSRSISQ 
Human AHCYL2  (101) GGEALVSPDGTVTEAPRTVKKQIQFADQKQEFNKRPTKIGRRSLSRSISQ 
   Consensus  (101)       S  ATVT AP   KKQIQFAD  QEF K PTK GRRSLSRSISQ 
                    151                                            200 
Human AHCYL1   (70) SSTDSYSSAASYTDSSDDEVSPREKQQTNSKGSSNFCVKNIKQAEFGRRE 
Human AHCYL2  (151) SSTDSYSSAASYTDSSDDETSPRDKQQKNSKGSSDFCVKNIKQAEFGRRE 
   Consensus  (151) SSTDSYSSAASYTDSSDDE SPRDKQQ NSKGSS FCVKNIKQAEFGRRE 
                    201                                            250 
Human AHCYL1  (120) IEIAEQDMSALISLRKRAQGEKPLAGAKIVGCTHITAQTAVLIETLCALG 
Human AHCYL2  (201) IEIAEQEMPALMALRKRAQGEKPLAGAKIVGCTHITAQTAVLMETLGALG 
   Consensus  (201) IEIAEQDM ALIALRKRAQGEKPLAGAKIVGCTHITAQTAVLIETL ALG 
                    251                                            300 
Human AHCYL1  (170) AQCRWSACNIYSTQNEVAAALAEAGVAVFAWKGESEDDFWWCIDRCVNMD 
Human AHCYL2  (251) AQCRWAACNIYSTLNEVAAALAESGFPVFAWKGESEDDFWWCIDRCVNVE 
   Consensus  (251) AQCRWAACNIYST NEVAAALAEAG  VFAWKGESEDDFWWCIDRCVNMD 
                    301                                            350 
human AHCYL1  (220) GWQANMILDDGGDLTHWVYKKYPNVFKKIRGIVEESVTGVHRLYQLSKAG 
human AHCYL2  (301) GWQPNMILDDGGDLTHWIYKKYPNMFKKIKGIVEESVTGVHRLYQLSKAG 
   Consensus  (301) GWQ NMILDDGGDLTHWIYKKYPNMFKKIKGIVEESVTGVHRLYQLSKAG 
                    351                                            400 
human AHCYL1  (270) KLCVPAMNVNDSVTKQKFDNLYCCRESILDGLKRTTDVMFGGKQVVVCGY 
human AHCYL2  (351) KLCVPAMNVNDSVTKQKFDNLYCCRESILDGLKRTTDMMFGGKQVVVCGY 
   Consensus  (351) KLCVPAMNVNDSVTKQKFDNLYCCRESILDGLKRTTDMMFGGKQVVVCGY 
                    401                                            450 
human AHCYL1  (320) GEVGKGCCAALKALGAIVYITEIDPICALQACMDGFRVVKLNEVIRQVDV 
human AHCYL2  (401) GEVGKGCCAALKAMGSIVYVTEIDPICALQACMDGFRLVKLNEVIRQVDI 
   Consensus  (401) GEVGKGCCAALKALGAIVYITEIDPICALQACMDGFRLVKLNEVIRQVDI 
                    451                                            500 
human AHCYL1  (370) VITCTGNKNVVTREHLDRMKNSCIVCNMGHSNTEIDVTSLRTPELTWERV 
human AHCYL2  (451) VITCTGNKNVVTREHLDRMKNSCIVCNMGHSNTEIDVASLRTPELTWERV 
   Consensus  (451) VITCTGNKNVVTREHLDRMKNSCIVCNMGHSNTEIDV SLRTPELTWERV 
                    501                                            550 
human AHCYL1  (420) RSQVDHVIWPDGKRVVLLAEGRLLNLSCSTVPTFVLSITATTQALALIEL 
human AHCYL2  (501) RSQVDHVIWPDGKRIVLLAEGRLLNLSCSTVPTFVLSITATTQALALIEL 
   Consensus  (501) RSQVDHVIWPDGKRIVLLAEGRLLNLSCSTVPTFVLSITATTQALALIEL 
                    551                                            600 
human AHCYL1  (470) YNAPEGRYKQDVYLLPKKMDEYVASLHLPSFDAHLTELTDDQAKYLGLNK 
human AHCYL2  (551) YNAPEGRYKQDVYLLPKKMDEYVASLHLPTFDAHLTELTDEQAKYLGLNK 
   Consensus  (551) YNAPEGRYKQDVYLLPKKMDEYVASLHLPSFDAHLTELTDDQAKYLGLNK 
                    601     611 
human AHCYL1  (520) NGPFKPNYYRY 
human AHCYL2  (601) NGPFKPNYYRY 
   Consensus  (601) NGPFKPNYYRY 
 
Figure 10: AHCYL1 and AHCYL2 Protein Alignment. The alignment above shows very high 
homology between AHCYL1 and AHCYL2. The alignment was created using Invitrogen’s Vector NTI 
software. The comparison between the proteins in the final 500 C-terminal amino acids showed 90.2% 
homology and 4.4% similarity. 
  
 Figure-11 below shows control (pre
violet staining of the cells of the confirmation screen; which was run in this project in 
attempt to confirm whether AHCYL1 and CDC42BPA 
senescence. Figure-11 shows the cells 11 days post infection
encoding siRNA that corresponded to AHCYL1 and CDC42BPA knockdown (see Table 
I for construct sequences). This figure suggests that knockdown 
affect cell density compared to non
CDC42BPA corresponds to a decrease in cell 
prior to GFP/Smurf2 C716A challenge. 
Figure 11: Crystal Violet Staining of Infected 
silencing shRNA, CDC42BPA silencing shRNA, or AHCYL1 silencing shRNA
stained with crystal violet (A). Magnification at 10X shows cell morphology
(B). 
 
 Figure-12 below shows the purity 
from WS1 cells infected with non-
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shRNA. The 28S, 18S, and 5S ribosomal RNA subunits are labeled. The clarity of these 
bands indicates that RNAse activity has not substantially degraded the RNA extracted 
from these cells; and that RNA isolated is pure enough for analysis with RT-qPCR. 
 
 
 
Figure 12: RNA Purity and Integrity.  Figure 12 shows the purity of the RNA samples extracted from 
WS1 cells (lane 2), WS1 cells transfected with a non-silencing shRNA (lane 3), WS1 cells transfected with 
CDC42BPA (lane 4), and WS1 cells transfected with AHCYL1 (lane 5). Lane 1 contained a PCR marker. 
The 28s, 18s, and 5s ribosomal RNA subunits are labeled. 
 
Figure-13 below shows crystal violet staining of the cells of the confirmation 
screen 10 days after infection with GFP.  This secondary infection acts as a control for 
the Smurf2 C716A challenge. This data correlates with that of Figure-11; cells with non-
silencing and AHCYL1 knockdown have similar density, and cells with CDC42BPA 
knockdown have lower density.  
28S 
18S 
 5S 
                1        2        3        4        5 
 Figure 13: GFP Control Secondary Infection of WS1 Cells.
expressing virus after infection with either; non
shRNA. Row 1 shows crystal violet plates, row 2 shows of 
 
Figure-14 below shows crystal violet staining of the cells of the confirmation 
screen 10 days after infection with Smurf2 C716A. 
density in the non-silencing shRNA com
32
 WS1 cells were infected with GFP 
-silencing shRNA, CDC42BPA shRNA, or AHCYL1 
crystal violet stained cells at 10X magnification. 
Crystal violet staining shows lower 
pared to CDC42BPA and AHCYL1 knockdown. 
 
 
 
 Figure 14: Smurf2 C716A Challenge S
Smurf2 C716A expressing virus after infection with either; non
AHCYL1 shRNA. Row 1 shows crystal violet plates, row 2 shows close up view of crystal violet stained 
cells at 10X magnification.  
 
  
Figure-15 below shows growth curve data collected from the AHCYL1 and non
silencing knockdown cells in the confirmation screen that were infected with either GFP 
(control) or Smurf2 C716A (challenge). These cells were plated four days post infection 
with GFP or C716A (day 1 count corresponds to five days post infection). The data show 
that AHCYL1/GFP growth rate is faster than non
that Smurf2 C716A challenge in AHCYL1 knockdown (dashed red line) correlates with a 
significant escape of senescence versus non
33
econdary Infection of WS1 Cells. WS1 cells were infected with 
-silencing shRNA, CDC42BPA shRNA, or 
-silencing/GFP. The data also showed 
-silencing knockdown (dashed blue line).
 
-
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Figure 15: AHCYL1 Knockdown Correlates with Escape of Smurf2 C716A Induced Senescence. Cell 
count data was collected for WS1 cells transfected with non-silencing shRNA/GFP (solid blue), non-
silencing shRNA/Smurf2 C716A (dashed blue), AHCYL1 shRNA/GFP (solid red), and AHCYL1 
shRNA/Smurf2 C716A (dashed red). Data shows that AHCYL1 cells challenged with Smurf2 C716A 
partially escape the control senescence phenotype (shown by non-silencing shRNA/Smurf2 C716A). 
 
 
Figure-16 below shows growth curve data collected from the CDC42BPA and 
non-silencing knockdown cells in the confirmation screen that were infected with either 
GFP (control) or Smurf2 C716A (challenge). These cells were plated four days post 
infection with GFP or C716A (day 1 count corresponds to five days post infection). The 
data show that CDC42BPA/GFP growth rate is comparable to that of non-silencing/GFP. 
The data also showed that Smurf2 C716A challenge in CDC42BPA knockdown (dashed 
green line) does not correlate with a significant escape of senescence versus non-
silencing knockdown (dashed blue line). 
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Figure 16: CDC42BPA Knockdown Does Not Correlate with Significant Escape of Smurf2 Induced 
C716A Senescence. Cell count data was collected for WS1 cells transfected with non-silencing 
shRNA/GFP (solid blue), non-silencing shRNA/Smurf2 C716A (dashed blue), CDC42BPA shRNA/GFP 
(solid green), and CDC42BPA/Smurf2 C716A (dashed green). Note that cell number was only sufficient to 
plate two wells for CDC42BPA/C716A cells; which were counted on days 1 and 6. This data does not 
show a significant escape from the C716A induced senescence.  
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DISCUSSION 
 
 
 This project was successful in using shRNA gene knockdown screening to 
identify candidate genes downstream of Smurf2 in senescence. Thirteen such genes were 
identified from the two screens run in this project. Two of the genes identified (AHCYL1 
and CDC42BPA) were investigated further in an attempt to confirm the correlation 
between the knockdown of these genes and escape of Smurf2-induced senescence. The 
preliminary data collected indicates that knockdown of AHCYL1 allows partial escape of 
senescence, while knockdown of CDC42BPA does not allow any significant escape from 
senescence. 
 
AHCYL1 and CDC42BPA 
 
AHCYL1 and CDC42BPA were two genes of interest identified in this project as 
potentially allowing escape from Smurf2-induced senescence in WS1 fibroblasts. The 
individual shRNA constructs that were pulled out of our screen were reordered and 
assessed individually in WS1 fibroblasts for escape of Smurf2 senescence. The 
information below briefly describes these two genes and provides the reasoning for 
studying them further. 
 
AHCYL1 
S-adenosylhomocysteine hydrolase-like 1, or AHCYL1 (a.k.a. IRBIT), was a 
gene that my screen suggested, when knocked down, allowed WS1 fibroblasts to escape 
Smurf2-induced senescence. ACHYL1 is a protein that catalyses the reaction S-adenosyl-
L-homocysteine + H2O = adenosine + L-homocysteine. The identification of this gene 
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was intriguing since AHCYL2, a homolog protein of AHCYL1,  has been implicated as a 
gene which plays a role in senescence (Berns et al., 2004). AHCYL2 has been shown to 
allow fibroblasts to escape senescence when knocked-down via RNAi. This escape of 
senescence in response to AHCYL2 knockdown was shown to act through the p53 
senescence pathway and not through the pRB pathway (Berns et al., 2004).  Knockdown 
of AHCYL2 did not affect p53 levels, but did lead to decreased p21 mRNA and protein 
levels, suggesting that AHCYL2 might act downstream of p53 (Berns et al., 2004). This 
downstream effect in senescence of p53 on AHCYL2, coupled with Smurf2’s link to p53 
induced senescence suggests that Smurf2 could affect AHCYL2.  
Could AHCYL1 function as its homolog does in senescence? In order to 
hypothesize the answer to this, AHCYL1 and AHCYL2 were aligned using Invitrogen’s 
Vector NTI software. This alignment showed very high similarity (Figure-10).  The 
similarity was greatest in the final 500 C-terminal amino acids of AHCYL1/AHCYL2, 
which showed 90.2% homology plus 4.4% similarity. The high level of homology 
between AHCYL1 and AHCYL2 brought forth the hypothesis that AHCYL1 might be 
downstream of Smurf2-p53 in fibroblast senescence (see Figure-17).   
 
CDC42BPA 
 
CDC42 binding protein kinase alpha, or CDC42BPA (a.k.a MRCK or MRCKα), 
was another gene that our screen suggested, when knocked down, allowed WS1 
fibroblasts to escape Smurf2-induced senescence. CDC42BPA acts alongside CDC42 in 
the MRCK-CDC42 nuclear movement signaling pathway (Ghomes et al., 2005). CDC42 
is a Rho GTPase that has also been identified as an effector of multiple signal 
transduction pathways, and has been shown to influence transcription factor activity 
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(Etienne-Manneville and Hall, 2002). Proteins in the Rho signaling pathway have been 
shown to contribute to cell cycle regulation, specifically in the progression of T-cells 
from G1 to S phase (Cantrell, 1998), and the initiation of S1 in quiescent fibroblasts 
(Olsen et al., 1995). This point is of particular interest because replicative senescence has 
been shown to stop fibroblasts from leaving G0/G1 and initiating S-phase. This 
information coupled with the discovery that CDC42BPA is regulated by Notch1 levels, 
which are regulated by p53, allowed us to hypothesize that CDC42BPA may act 
downstream of p53 (Lefort et al., 2007) (see Figure-17).  
 
 
 
Figure 17: AHCYL1’s and CDC42BPA’s Hypothesized Role in Senescence. CDC42BPA has been 
shown to act downstream of p53 via a Notch1 intermediate. AHCYL2, a close relative of AHCYL1, has 
been shown to act downstream of p53 allowing us to hypothesize AHCYL1 might act downstream of p53. 
p53 has been shown to change the transcriptional levels of many other genes, some of which this figure 
presumes influence the senescence signal. 
 
 
Future Directions 
The shRNA constructs shown in Table I of this project were found in only a 
single colony in the screen; suggesting that the screen was not run to saturation. If the 
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screen were saturated, one would expect to pick up multiple colonies containing the same 
shRNA construct. In order to ensure saturation of the screen, the same shRNA pools 
should be screened in the same manner until some of the shRNA constructs are isolated 
from Smurf2-induced senescence escaping cells multiple times. 
In order to identify as many genes downstream of Smurf2 as possible, another set 
of screens should be run using the 35,000 other unique shRNA constructs that are part of 
the human pGIPZ library (65,000 constructs total). This would ensure that all genes 
effected by the pGIPZ shRNA library are tested for escape from Smurf2-induced 
senescence. 
All of the constructs in Table I should be ordered and screened in the same way 
AHCYL1 and CDC42BPA were in this project in order to identify which candidates 
allow significant escape from senescence. Furthermore, any gene whose expression arrest 
correlates with Smurf2-induced senescence escape should be studied further to 
understand its precise role in the senescence pathway. 
RNA extracted in this project from WS1 cells (uninfected, non-silencing, 
AHCYL1, and CDC42BPA) should be analyzed for changes in transcript levels of key 
genes in the senescence pathway. First, this analysis should determine the amount of 
knockdown that occurs in the target genes in response to shRNA infection. Also, 
transcript levels for Smurf2, p53, and p21 should be analyzed to see if the knockdown of 
AHCYL1 or CDC42BPA correlates with changes in expression of these genes.   
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